TrialOncotarget2017

Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study.

Huan Tong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.